SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001640334-18-000408
Filing Date
2018-03-01
Accepted
2018-03-01 06:18:42
Documents
38
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q etbi_10qa.htm 10-Q/A 329896
2 CERTIFICATION etbi_ex311.htm EX-31.1 7170
3 CERTIFICATION etbi_ex312.htm EX-31.2 7182
4 CERTIFICATION etbi_ex321.htm EX-32.1 3189
5 CERTIFICATION etbi_ex322.htm EX-32.2 3370
  Complete submission text file 0001640334-18-000408.txt   1609030

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT etbi-20160630.xml EX-101.INS 192753
7 XBRL TAXONOMY EXTENSION SCHEMA etbi-20160630.xsd EX-101.SCH 27027
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE etbi-20160630_cal.xml EX-101.CAL 35515
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE etbi-20160630_def.xml EX-101.DEF 69387
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE etbi-20160630_lab.xml EX-101.LAB 151853
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etbi-20160630_pre.xml EX-101.PRE 124132
Mailing Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109 8013223401
EASTGATE BIOTECH CORP (Filer) CIK: 0001099574 (see all company filings)

IRS No.: 870639378 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-52886 | Film No.: 18654616
SIC: 6799 Investors, NEC